Description
Xbira™ is a quality assured generic of Zytiga® used in combination with prednisone to treat metastatic castration resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) in adult men. It’s produced in a US FDA approved factory in India.
Bottle Size : 120 Tablets (250 mg strength), 60 Tablets (500 mg strength)
Active Ingredients : Abiraterone Acetate
Produced by Cipla Inc®